<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H70DA5E3CA9094D67A80DDD2006B8409B" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 1348 IH: Investing in Testing Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-03-02</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1348</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20170302">March 2, 2017</action-date><action-desc><sponsor name-id="M001185">Mr. Sean Patrick Maloney of New York</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To require the Director of the Centers for Disease Control and Prevention to complete a study on
			 the human health implications of per- and polyfluoroalkyl substances
			 (PFAS) contamination in drinking water.</official-title></form>
	<legis-body id="H5EEE18CC7F2E49BDB84AF10187C1A122" style="OLC">
 <section id="H5FE3ACADEAA84537BB3391C222829F42" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Investing in Testing Act of 2017</short-title></quote>.</text> </section><section id="H9D4F45C898D54EA8B264E7DD973B7909"><enum>2.</enum><header>Study by CDC on health implications of per- and polyfluoroalkyl substances contamination in drinking water</header> <subsection id="HFC1D6D52A89B4379923C78B6073D7468"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Director of the Centers for Disease Control and Prevention shall—</text>
 <paragraph id="H498513A2D8B54AE798BFE308328201B5"><enum>(1)</enum><text display-inline="yes-display-inline">not later than 60 days after the date of enactment of this Act, commence a study on the human health implications of per- and polyfluoroalkyl substances (PFAS) contamination in drinking water; and</text>
 </paragraph><paragraph id="H3AEA2057601747F699C4C64FBE25680E"><enum>(2)</enum><text display-inline="yes-display-inline">not later than 2 years and 60 days after the date of enactment of this Act—</text> <subparagraph id="HFB641A81E969447AB602564893D0E935"><enum>(A)</enum><text>complete such study; and</text>
 </subparagraph><subparagraph id="H5D58D89407EB4B86939F232AF39760AB"><enum>(B)</enum><text>submit a report to the Congress on the results of such study.</text> </subparagraph></paragraph></subsection><subsection id="HD6775E60BFD641758C6F7E0616876FDD"><enum>(b)</enum><header>Authorization of appropriations</header><text>To carry out this Act, there is authorized to be appropriated $15,000,000.</text>
			</subsection></section></legis-body></bill>


